Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
1 μM and IL4 driven proliferation with IC50=0
MDV-3100 also prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex
In contrast
(1997) Oncogene
gerbil and monkey NK1 receptors over rat
MBX-2982 - CAS# 1037792-44-1 size:2mg solid 1 μM and IL4 drivenMBX 2982, also known as SAR 260093, CAS No. 1037792 44 1, is a potential first in class treatment for type 2 diabetes that targets G protein coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose dependent insulin secretion. Preclinical data indicate that MBX 2982 is a potent selective orally active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the
US$ 11597.50
US$ 754.00